Molecular Partners Heads Into Earnings With a Stock at Multi-Year Lows
MOLN reports this morning with the stock sitting at CHF 3.14 — down 7% over the past month and roughly flat with where insiders have been quietly selling for over a year. The setup is not one of aggressive short…
